ZOMDF

PINK Zomedica Corp

Oct 24, 2026 · 4:55 AM ET EOD Market Closed

$0.0824 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0824, and at the day’s high of $0.0825

YTD change: -19.02%
vs 20-day SMA: +1.60%
vs 200-day SMA: -19.91%

Price ranges

Previous day

$0.0779 $0.0825

open $0.0780 close $0.0824

+$0.0045 (+5.71%)

Today

$0.0779 $0.0825

$0.0824

Past week

$0.0750 $0.0850

from $0.0818 now $0.0824

+$0.0006 (+0.73%)

Past month

$0.0700 $0.0888

from $0.0735 now $0.0824

+$0.0089 (+12.11%)

This year

$0.0700 $0.1580

from $0.1018 now $0.0824

-$0.0194 (-19.02%)

Price & Performance

-0.02 (-16.85%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral

The stock is 47.8% away from all-time highs of $0.1580
ZOMDF is down 19% since the beginning of the year
ZOMDF is up 13% over the past 12 months
ZOMDF is up 12% over the past 1 month
0% of all ZOMDF investors are betting against ZOMDF

ZOMDF reads neutral: price sits above one of the two key moving averages, the 12-month move is +15.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No

EPS $-0.0038

Earnings momentum N/A Quarterly EPS growth

Quarterly change N/A

Valuation

P/E ratio N/A

Enterprise value $34.0M

Beta 1.10

Balance sheet & scale

IncomeN/A

Revenue$36.6M

Cash$44.1M

Debt$1.8K

Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangePINK

Sector Professional, Scientific, and Technical Services

Industry Group Other Professional, Scientific, and Technical Services

Market cap $80.7M

Zomedica Corp. engages in the discovery, development, and commercialization of pharmaceuticals for companion animals, including dogs, cats, and horses. The firm offers products focusing on the unmet needs of clinical veterinarians. It operates through the following segments: Diagnostics, Therapeutic Devices, and Development Services. The Diagnostics segment offers TRUFORMA, VETGuardian and TRUVIEW products. The Therapeutic Devices segment consists of Assisi, PulseVet and VETIGEL products. The Development Services segment includes contract manufacturing and engineering services. The company was founded by Gerald L. Solensky on January 7, 2013 and is headquartered in Ann Arbor, MI.

Competitor comparison

Ticker	Company	Price	Change
IDXX	IDEXX Laboratories, Inc.	$560.38	-1.13%
IVPR	Inspire Veterinary Partners, Inc. Class A	$0.0001	+0.00%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.